BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 28205498)

  • 1. Cognitive Control, Learning, and Clinical Motor Ratings Are Most Highly Associated with Basal Ganglia Brain Volumes in the Premanifest Huntington's Disease Phenotype.
    Misiura MB; Lourens S; Calhoun VD; Long J; Bockholt J; Johnson H; Zhang Y; Paulsen JS; Turner JA; Liu J; Kara B; Fall E;
    J Int Neuropsychol Soc; 2017 Feb; 23(2):159-170. PubMed ID: 28205498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal ganglia-cortical structural connectivity in Huntington's disease.
    Novak MJ; Seunarine KK; Gibbard CR; McColgan P; Draganski B; Friston K; Clark CA; Tabrizi SJ
    Hum Brain Mapp; 2015 May; 36(5):1728-40. PubMed ID: 25640796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional atrophy associated with cognitive and motor function in prodromal Huntington disease.
    Aylward EH; Harrington DL; Mills JA; Nopoulos PC; Ross CA; Long JD; Liu D; Westervelt HK; Paulsen JS;
    J Huntingtons Dis; 2013; 2(4):477-89. PubMed ID: 25062732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional subcortical shape analysis in premanifest Huntington's disease.
    Tang X; Ross CA; Johnson H; Paulsen JS; Younes L; Albin RL; Ratnanather JT; Miller MI
    Hum Brain Mapp; 2019 Apr; 40(5):1419-1433. PubMed ID: 30376191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal ganglia volume and clinical correlates in 'preclinical' Huntington's disease.
    Jurgens CK; van de Wiel L; van Es AC; Grimbergen YM; Witjes-Ané MN; van der Grond J; Middelkoop HA; Roos RA
    J Neurol; 2008 Nov; 255(11):1785-91. PubMed ID: 19156490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apathy Is Related to Cognitive Control and Striatum Volumes in Prodromal Huntington's Disease.
    Misiura MB; Ciarochi J; Vaidya J; Bockholt J; Johnson HJ; Calhoun VD; Paulsen JS; Turner JA;
    J Int Neuropsychol Soc; 2019 May; 25(5):462-469. PubMed ID: 30806337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.
    Unschuld PG; Edden RA; Carass A; Liu X; Shanahan M; Wang X; Oishi K; Brandt J; Bassett SS; Redgrave GW; Margolis RL; van Zijl PC; Barker PB; Ross CA
    Mov Disord; 2012 Jun; 27(7):895-902. PubMed ID: 22649062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
    Tabrizi SJ; Scahill RI; Durr A; Roos RA; Leavitt BR; Jones R; Landwehrmeyer GB; Fox NC; Johnson H; Hicks SL; Kennard C; Craufurd D; Frost C; Langbehn DR; Reilmann R; Stout JC;
    Lancet Neurol; 2011 Jan; 10(1):31-42. PubMed ID: 21130037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT-HD.
    Long JD; Paulsen JS;
    Mov Disord; 2015 Oct; 30(12):1664-72. PubMed ID: 26340420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological manifestations of the genetic mutation for Huntington's disease in presymptomatic individuals.
    Brandt J; Shpritz B; Codori AM; Margolis R; Rosenblatt A
    J Int Neuropsychol Soc; 2002 Nov; 8(7):918-24. PubMed ID: 12405543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
    Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA
    J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study.
    Politis M; Pavese N; Tai YF; Kiferle L; Mason SL; Brooks DJ; Tabrizi SJ; Barker RA; Piccini P
    Hum Brain Mapp; 2011 Feb; 32(2):258-70. PubMed ID: 21229614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.
    Coppen EM; Jacobs M; van den Berg-Huysmans AA; van der Grond J; Roos RAC
    Parkinsonism Relat Disord; 2018 Jan; 46():56-61. PubMed ID: 29128164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.
    Podvin S; Reardon HT; Yin K; Mosier C; Hook V
    J Neurol; 2019 Mar; 266(3):551-564. PubMed ID: 29956026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal changes in functional connectivity of cortico-basal ganglia networks in manifests and premanifest huntington's disease.
    Gargouri F; Messé A; Perlbarg V; Valabregue R; McColgan P; Yahia-Cherif L; Fernandez-Vidal S; Ben Hamida A; Benali H; Tabrizi S; Durr A; Lehéricy S
    Hum Brain Mapp; 2016 Nov; 37(11):4112-4128. PubMed ID: 27400836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressive symptoms in prodromal Huntington's Disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex.
    Unschuld PG; Joel SE; Pekar JJ; Reading SA; Oishi K; McEntee J; Shanahan M; Bakker A; Margolis RL; Bassett SS; Rosenblatt A; Mori S; van Zijl PC; Ross CA; Redgrave GW
    Psychiatry Res; 2012; 203(2-3):166-74. PubMed ID: 22974690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic characteristics in patients with Huntington's disease from China.
    Yang J; Chen K; Wei Q; Chen Y; Cao B; Burgunder JM; Shang HF
    Neurol Res; 2016 Oct; 38(10):916-20. PubMed ID: 27483361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load.
    Wolf RC; Sambataro F; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer B
    Eur J Neurol; 2008 Nov; 15(11):1180-90. PubMed ID: 18754766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early grey matter changes in structural covariance networks in Huntington's disease.
    Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
    Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.